There was a mention from Stamler several months ago, that they expect a fast track from the FDA, and believe they should get FDA approval within 6mnths from the final readout, as ATH434 is a novel orphan drug and being used for MSA pts who have no treatment.
Regarding this summit presentation, is it quite prestigeous, in that it has a very select invite ?.
Ann: ATH to Participate in 2024 Maxim Healthcare Virtual Summit, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $45.25K | 4.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 11296464 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 7952306 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |